Amneal Pharmaceuticals (AMRX) Earns A+ for Value, Buy Rating

Amneal Pharmaceuticals (AMRX) is a value stock with a Zacks Rank #2 (Buy) and an A grade for Value. It has a P/S ratio of 1.55, compared to its industry's average of 4.46, and a P/CF ratio of 10.89, compared to its industry's average of 14.01. These metrics suggest that AMRX is undervalued and a strong value stock.